Crystal arthritis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) (→Causes) |
||
| (7 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Crystal induced arthritis is a relatively common condition that involves deposition of crystals in [[Joint|joints]] and soft tissues. A variety of crystals can deposit in and around [[Joint|joints]] and soft tissues, resulting in [[articular]] and periarticular inflammation. Monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD) are the most commonly involved crystals in the pathogenesis of crystal induced [[Arthropathy|arthropathies]]. Other rare types of crystal arthropathy include [[Hydroxylapatite|hydroxyapatite]] crystal deposition [[arthropathy]]. [[Gout]] and [[Pseudogout|pseudo-gout]] manifest with similar symptoms, and cannot be distinguished clinically. [[Synovial fluid]] analysis the involved joint is essential to diagnose and differentiation of crystal induced arthropathies. | Crystal induced arthritis is a relatively common condition that involves deposition of crystals in [[Joint|joints]] and soft tissues. A variety of [[Crystal|crystals]] can deposit in and around [[Joint|joints]] and soft tissues, resulting in [[articular]] and periarticular inflammation. [[Urate|Monosodium urate (MSU)]] and [[Calcium pyrophosphate|calcium pyrophosphate dihydrate (CPPD)]] are the most commonly involved crystals in the pathogenesis of crystal induced [[Arthropathy|arthropathies]]. Other rare types of crystal arthropathy include [[Hydroxylapatite|hydroxyapatite]] crystal deposition [[arthropathy]]. [[Gout]] and [[Pseudogout|pseudo-gout]] manifest with similar symptoms, and cannot be distinguished clinically. [[Synovial fluid]] analysis the involved joint is essential to diagnose and differentiation of crystal induced arthropathies. | ||
==Causes== | ==Causes== | ||
Common causes of crystal arthritis include: | |||
*[[Gout]] | *[[Gout]] | ||
*[[Pseudogout]] (Calcium pyrophosphate dihydrate) | *[[Pseudogout]] ([[Calcium pyrophosphate|Calcium pyrophosphate dihydrate]]) | ||
*[[Calcium apatite deposition disease]] | *[[Calcium apatite deposition disease]] | ||
| Line 30: | Line 32: | ||
{| class="wikitable" | {| class="wikitable" | ||
! | ! style="background:#4479BA; color: #FFFFFF;" align="center" + | | ||
!Gout | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Gout | ||
!Pseudogout | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pseudogout | ||
|- | |- | ||
|Definition | | style="background:#DCDCDC; + " |'''Definition''' | ||
| | | | ||
* Supersaturation of [[Extracellular fluid|extracellular fluids]] and [[Blood plasma|plasma]] with [[uric acid]] leading to monosodium urate (MSU) crystal deposition in the [[joint]] spaces is called gout. | * Supersaturation of [[Extracellular fluid|extracellular fluids]] and [[Blood plasma|plasma]] with [[uric acid]] leading to monosodium urate (MSU) crystal deposition in the [[joint]] spaces is called gout. | ||
| Line 40: | Line 42: | ||
* Acute and chronic inflammatory joint disease leading to deposition of [[Calcium pyrophosphate|calcium pyrophosphate dihydrate (CPPD)]] deposition in the joints leads to [[Chondrocalcinosis|pseudogout]]. | * Acute and chronic inflammatory joint disease leading to deposition of [[Calcium pyrophosphate|calcium pyrophosphate dihydrate (CPPD)]] deposition in the joints leads to [[Chondrocalcinosis|pseudogout]]. | ||
|- | |- | ||
|Pathogenesis | | style="background:#DCDCDC; + " |'''Pathogenesis''' | ||
| | | | ||
* Increased production or decreased excretion of [[uric acid]] leads to hyperuricemia. | * Increased production or decreased excretion of [[uric acid]] leads to hyperuricemia. | ||
| Line 46: | Line 48: | ||
* Shedding from [[Cartilage|articular cartilage]] into joint space where they are phagocytosed by [[Neutrophil|neutrophils]] and incite an inflammatory response, leading to [[Crystal|crystal formation]]. | * Shedding from [[Cartilage|articular cartilage]] into joint space where they are phagocytosed by [[Neutrophil|neutrophils]] and incite an inflammatory response, leading to [[Crystal|crystal formation]]. | ||
|- | |- | ||
|Clinical Features | | style="background:#DCDCDC; + " |'''Clinical Features''' | ||
| | | | ||
* [[Arthritis|Acute arthritis]]: | * [[Arthritis|Acute arthritis]]: | ||
| Line 71: | Line 73: | ||
* Symmetric proliferative synovitis | * Symmetric proliferative synovitis | ||
|- | |- | ||
|Diagnosis | | style="background:#DCDCDC; + " |'''Diagnosis''' | ||
| | | | ||
* [[Aspiration|Joint | * [[Aspiration|Joint aspiration]] | ||
** [[Synovial fluid]] analysis shows both intracellular and extracellular needle-shaped negatively birefringent MSU crystals by polarizing microscopy | ** [[Synovial fluid]] analysis shows both intracellular and extracellular needle-shaped negatively birefringent MSU crystals by polarizing microscopy | ||
| Line 85: | Line 87: | ||
** Demonstration of CPPD crystals appearing as rhomboids with weak positive birefringece by polarizing microscopy | ** Demonstration of CPPD crystals appearing as rhomboids with weak positive birefringece by polarizing microscopy | ||
|- | |- | ||
|Treatment | | style="background:#DCDCDC; + " |'''Treatment''' | ||
| | | | ||
* [[Analgesia]] | * [[Analgesia]] | ||
| Line 94: | Line 96: | ||
* [[Probenecid]], [[Sulfinpyrazone]] | * [[Probenecid]], [[Sulfinpyrazone]] | ||
| | | | ||
* NSAIDs | * [[Non-steroidal anti-inflammatory drug|NSAIDs]] | ||
* Intraarticular injection of glucocorticoids | * Intraarticular injection of [[glucocorticoids]] | ||
* Colchicine | * [[Colchicine]] | ||
|} | |} | ||
Latest revision as of 22:01, 5 July 2020
|
Crystal arthritis Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2] Sudarshana Datta, MD [3]
Overview
Crystal induced arthritis is a relatively common condition that involves deposition of crystals in joints and soft tissues. A variety of crystals can deposit in and around joints and soft tissues, resulting in articular and periarticular inflammation. Monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD) are the most commonly involved crystals in the pathogenesis of crystal induced arthropathies. Other rare types of crystal arthropathy include hydroxyapatite crystal deposition arthropathy. Gout and pseudo-gout manifest with similar symptoms, and cannot be distinguished clinically. Synovial fluid analysis the involved joint is essential to diagnose and differentiation of crystal induced arthropathies.
Causes
Common causes of crystal arthritis include:
Classification
| Arthritis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inflammatory | Non-Inflammatory | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Osteoarthritis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rheumatoid factor | Infectious | Crystalloid | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rheumatoid positive | Rheumatoid negative | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RA Lupus Scleroderma | AKS Psoriatic arthritis Reactive arthritis | Gout | Pseudogout | Calcium hydroxapatite crystals | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differentiating Gout from Pseudogout
Gout can be differentiated from pseudogout based on the following characteristics:
| Gout | Pseudogout | |
|---|---|---|
| Definition |
|
|
| Pathogenesis |
|
|
| Clinical Features |
|
|
| Diagnosis |
|
|
| Treatment |
|